In 2019, Georgia reported a low HIV prevalence of 0.4%, with the highest rates among people who inject drugs (PWID), men who have sex with men (MSM), and female sex workers (FSWs). While HIV rates among PWID and FSWs remained stable, the HIV prevalence among MSM continued to be high.<\/p>\n
The country made significant progress through the expansion of the PrEP program and increased state funding for HIV treatment. By 2019, the HIV program was largely focused on achieving global targets and ensuring the long-term sustainability of services without excessive reliance on international funding.<\/p>\n
By 2023, HIV prevalence among MSM in Georgia had decreased to just over 15%, still 26 times higher than in the general population. Advocacy efforts led to political progress, with the government prioritizing HIV prevention among key populations and their sexual partners. HIV testing services are also provided free of charge for everyone. In 2017, Georgia became the first country in Eastern Europe and Central Asia to introduce pre-exposure prophylaxis (PrEP) for MSM and transgender people.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n